L&C Bio rights offering: existing shareholder subscription rate at 103.92%
Predicted impact: Low· Actual: −0.7% vs sector, volume 1.6× normal (5 trading days)
Subscription rate result of the same rights offering already flagged; lowered one level.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.